五月天堂婷婷爱,色狠狠天天综合色香阁,91免费看国产,久久久久成人精品亚洲国产av综合,91啦在线播放,免费a一级毛片在线播放,天天日日夜夜看综合网,亚洲成人国产精品,奇米影视7777狠狠狠狠色,日韩精品高清在线观看,福利久久久,久久99国产精品片久久99蜜桃,91香蕉视频网址,婷婷91,久久久久久臀欲欧美日韩,少妇丰满大乳被男人揉捏视频

Clinical trial data is required for FDA registration and certification depending on the type of product and the submission pathway:

1. Premarket Approval (PMA):

   • Clinical Trials: Yes, clinical trial data is typically required to demonstrate the safety and effectiveness of high-risk medical devices. PMA submissions usually include extensive clinical study results.

2. 510(k) Clearance:

   • Clinical Trials: Not usually required. Instead, 510(k) submissions often rely on existing data and comparisons with legally marketed devices to demonstrate substantial equivalence. However, if substantial changes have been made to a device, clinical data may be needed.

3. De Novo Classification:

   • Clinical Trials: May be required depending on the device's risk and novelty. Clinical data helps establish the device's safety and effectiveness when there is no existing predicate device.

4. In Vitro Diagnostic Devices (IVDs):

   • Clinical Trials: Clinical data may be required to validate the device's performance and accuracy, especially for high-risk IVDs.

5. Drug-Device Combinations:

   • Clinical Trials: Clinical data is often required to support the safety and efficacy of the combined product.

In summary, clinical trial data is generally required for higher-risk devices and some novel devices but may not be necessary for lower-risk devices or those similar to existing products.